AnaptysBio, Inc.
PD-1 AGONIST AND METHOD OF USING SAME
Last updated:
Abstract:
Provided is a PD-1-binding agent comprising an immunoglobulin heavy chain polypeptide and immunoglobulin light chain polypeptide, as well as related compositions and methods for making and using same.
Status:
Application
Type:
Utility
Filling date:
4 Jun 2020
Issue date:
28 Jul 2022